首页> 外文期刊>Expert review of anti-infective therapy >Potentiation of antimicrobial photodynamic inactivation by inorganic salts
【24h】

Potentiation of antimicrobial photodynamic inactivation by inorganic salts

机译:无机盐的抗微生物光动力动力灭活的增强

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Antimicrobial photodynamic inactivation (aPDI) involves the use of non-toxic dyes excited with visible light to produce reactive oxygen species (ROS) that can destroy all classes of microorganisms including bacteria, fungi, parasites, and viruses. Selectivity of killing microbes over host mammalian cells allows this approach (antimicrobial photodynamic therapy, aPDT) to be used in vivo as an alternative therapeutic approach for localized infections especially those that are drug-resistant.Areas covered: We have discovered that aPDI can be potentiated (up to 6 logs of extra killing) by the addition of simple inorganic salts. The most powerful and versatile salt is potassium iodide, but potassium bromide, sodium thiocyanate, sodium azide and sodium nitrite also show potentiation. The mechanism of potentiation with iodide is likely to be singlet oxygen addition to iodide to form iodine radicals, hydrogen peroxide and molecular iodine. Another mechanism involves two-electron oxidation of iodide/bromide to form hypohalites. A third mechanism involves a one-electron oxidation of azide anion to form azide radical.Expert commentary: The addition of iodide has been shown to improve the performance of aPDT in several animal models of localized infection. KI is non-toxic and is an approved drug for antifungal therapy, so its transition to clinical use in aPDT should be straightforward.
机译:介绍:抗微生物光动力学失活(APDI)涉及使用可见光激发的无毒染料,以产生可破坏所有类微生物,包括细菌,真菌,寄生虫和病毒的反应性氧物质(ROS)。在宿主哺乳动物细胞上杀死微生物的选择性允许这种方法(抗微生物光动力治疗,APDT)作为局部感染的替代治疗方法,尤其是耐药的局部感染。覆盖:我们已经发现了APDI可以提高(加入简单的无机盐,最多6次报废额外杀戮。最强大和最通用的盐是碘化钾,但溴化钾,硫氰酸钠,叠氮化钠和亚硝酸钠也显示出具有增强。用碘化物的增强机制可能是碘化物的单线氧,形成碘基团,过氧化氢和分子碘。另一种机制涉及两电子氧化碘/溴化物以形成HopOhalite。第三种机制涉及叠氮化物阴离子的单电子氧化,形成叠氮化物。富评注释:已经显示碘化物的添加以改善局部感染的几种动物模型中APDT的性能。 Ki是无毒的,是一种批准的抗真菌药物,所以它在APDT中的临床使用过渡应该是直截了当的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号